Late Recurrence of High-Grade Vulvar Leiomyosarcoma After 5 Years: A Rare Case Report and Expanded Review of Reported Cases
Journal of Clinical Medicine · 26.08.2025 · 14 (17) · 6032
DOI: 10.3390/jcm14176032 ↗Kurz gefasst
Fallbericht in der Zeitschrift Journal of Clinical Medicine, online erschienen am 26.08.2025. Verfasst von Angel Yordanov und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Gynaecological Oncology, Medical University Pleven, 5800 Pleven, Bulgaria. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 26 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Background
Vulvar leiomyosarcoma (VLMS) is a rare and aggressive soft tissue malignancy arising from smooth muscle cells, comprising less than 3% of vulvar cancers. Its clinical resemblance to benign vulvar lesions often leads to delayed diagnosis. Despite surgical resection and adjuvant therapy, VLMS is associated with high recurrence rates and a poor prognosis, and due to its rarity, there is no standardized management or surveillance protocol. Case Report: We present a case of high-grade VLMS in a postmenopausal woman, initially diagnosed in 2020 and managed with surgical excision and adjuvant radiotherapy. The primary tumor was a 10 cm solid, lobulated mass involving the mons pubis, with histology confirming high-grade leiomyosarcoma based on marked cellular atypia, high mitotic activity, and smooth muscle differentiation. Immunohistochemistry was positive for SMA, vimentin, and CD34, and negative for S100 and MyoD1. Five years later, the patient developed a local recurrence with an enlarged inguinal lymph node. She underwent complete tumor resection and bilateral inguinal lymphadenectomy. Histology of the recurrent lesion mirrored the initial findings, with no lymph node metastases. This case highlights the aggressive nature and potential for late recurrence in vulvar leiomyosarcoma, underscoring the importance of long-term surveillance.
Conclusions
High-grade VLMS is a rare malignancy with a high recurrence risk. This case highlights the importance of early diagnosis, radical surgical treatment, and long-term surveillance. Although recurrence occurred five years after the initial treatment, timely surgical intervention led to a favorable postoperative course. Multidisciplinary management and individualized follow-up strategies remain key to improving outcomes in these rare gynecologic sarcomas.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Gynaecological Oncology, Medical University Pleven, 5800 Pleven, Bulgaria.
- Department of General and Clinical Pathology, University Hospital "Dr. Georgi Stranski", 5800 Pleven, Bulgaria.
- Department of Gynaecology, St. Anna University Hospital, 9002 Varna, Bulgaria.
- Research Institute, Medical University Pleven, 5800 Pleven, Bulgaria.
- Department of Obstetrics and Gynecology, University Hospital "Sofiamed", 1000 Sofia, Bulgaria.
- Faculty of Medicine, Medical University Pleven, 5800 Pleven, Bulgaria.
ORCID-Profile: Angel Yordanov, Stoyan Kostov
Zitieren
APA
Yordanov, A., Ivanov, I., Kostov, S., Hasan, I., & Dimitrova, V. (2025). Late Recurrence of High-Grade Vulvar Leiomyosarcoma After 5 Years: A Rare Case Report and Expanded Review of Reported Cases. Journal of Clinical Medicine, 14(17), 6032. https://doi.org/10.3390/jcm14176032
Vancouver
Yordanov A, Ivanov I, Kostov S, Hasan I, Dimitrova V. Late Recurrence of High-Grade Vulvar Leiomyosarcoma After 5 Years: A Rare Case Report and Expanded Review of Reported Cases. Journal of Clinical Medicine. 2025;14(17):6032. doi:10.3390/jcm14176032
BibTeX
@article{Yordanov2025,
author = {Yordanov, Angel and Ivanov, Ivan and Kostov, Stoyan and Hasan, Ihsan and Dimitrova, Vasilena},
title = {Late Recurrence of High-Grade Vulvar Leiomyosarcoma After 5 Years: A Rare Case Report and Expanded Review of Reported Cases},
journal = {Journal of Clinical Medicine},
year = {2025},
volume = {14},
number = {17},
pages = {6032},
doi = {10.3390/jcm14176032}
}
EUVIMED